BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
My experience at BRT has been very positive from the work itself with driven purpose to the culture and individual team members striving for the best in science, work output, and truly working as a team.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Spirit and trying their best to help via PRC
Quelle est la meilleure partie de votre programme de rémunération?
The benefit package including retirement
Quelles sont les meilleures choses à propos de votre équipe?
Colleagues are willing to listen to ideas in general
Qu’est-ce qui vous rend le plus heureux au travail?
It's a combination of the science and the colleagues.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
People trying to solve problems and move forward while listening to team members
Other Employee Reviews for BlueRock Therapeutics
×